select a format

Single User License
USD 250 INR 16248
Site License
USD 500 INR 32495
Corporate User License
USD 750 INR 48743

Alternatively

Request a quote
Request a Customized research
Request for Sample Report

NEWSLETTER BY CATEGORY




Recent Viewed Reports


Why Ken Reasearch?


Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements.... "Senior Associate, Booz Allen Hamilton"

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"


Northwest Biotherapeutics Inc (NWBO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Northwest Biotherapeutics Inc (NWBO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH62423D
  • |
  • Pages: 39
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. Using its proprietary technology platform, DCVax, the company developed a robust pipeline of therapeutic product candidates. DCVax is a personalized immune therapy and consists of therapeutic vaccine which uses patient's own dendritic cells as the therapeutic agent. The product has two components, namely, dendritic cells (immune cells) and antigens (cancer biomarkers). The company's product lines include DCVax-L, for the treatment of glioblastoma multiforme (GBM) brain cancer (Phase III) and metastatic ovarian cancer (Phase I completed); DCVax-Direct, for the treatment of all solid tumor cancers (Phase I/II underway) and colon cancer metastases (Phase I/II planned); and DCVax-Prostate, for the treatment of late stage prostate cancer (Phase III approved by FDA). NW Bio is headquartered in Bethesda, Maryland, the US.

Northwest Biotherapeutics Inc (NWBO)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Northwest Biotherapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12

Equity Offering 12

Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 12

Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 13

Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 14

Northwest Biotherapeutics to Raise USD3.7 Million in Private Placement of Shares 15

Northwest Biotherapeutics to Raise USD27.6 Million in Private Placement of Shares 16

Northwest Biotherapeutics Raises USD12.6 Million in Private Placement of Shares 17

Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 19

Northwest Biotherapeutics Raises USD40 Million in Private Placement of Shares 20

Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 21

Northwest Biotherapeutics Raises USD11.5 Million in Private Placement of Shares 22

Northwest Biotherapeutics Completes Private Placement Of Shares For US$15 Million 23

Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 24

Northwest Biotherapeutics Completes Private Placement Of Units For US$15 Million 25

Northwest Biotherapeutics Completes Private Placement Of Shares For US$10 Million 27

Northwest Biotherapeutics Completes Public Offering Of Shares For US$14 Million 27

Northwest Biotherapeutics Completes Private Placement Of Shares For US$5 Million 29

Northwest Biotherapeutics Announces Private Placement Of Shares For US$3 Million 30

Debt Offering 31

Northwest Biotherapeutics Raises USD17.5 Million in Private Placement of 5% Notes Due 2017 31

Northwest Biotherapeutics Completes Private Placement Of Convertible Notes For US$3 Million 32

Northwest Biotherapeutics Inc-Key Competitors 34

Key Employees 35

Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 37

Corporate Communications 37

Dec 19, 2016: NW Bio Announces Initiation Of Trading On The OTCQB Marketplace Starting On Monday Morning, December 19, 2016 37

Jan 25, 2016: NW Bio Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations Expertise 38

Appendix 39

Methodology 39

About GlobalData 39

Contact Us 39

Disclaimer 39

List of Figures

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Northwest Biotherapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Northwest Biotherapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Northwest Biotherapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 9

Northwest Biotherapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Northwest Biotherapeutics Raises USD7.5 Million in Private Placement of Shares and Warrants 12

Northwest Biotherapeutics to Raise USD10 Million in Private Placement of Shares and Warrants 13

Northwest Biotherapeutics to Raise USD5.3 Million in Private Placement of Shares 14

Northwest Biotherapeutics to Raise USD3.7 Million in Private Placement of Shares 15

Northwest Biotherapeutics to Raise USD27.6 Million in Private Placement of Shares 16

Northwest Biotherapeutics Raises USD12.6 Million in Private Placement of Shares 17

Northwest Biotherapeutics to Raise USD30 Million in Private Placement of Shares 19

Northwest Biotherapeutics Raises USD40 Million in Private Placement of Shares 20

Northwest Biotherapeutics Raises USD25 Million in Private Placement of Shares 21

Northwest Biotherapeutics Raises USD11.5 Million in Private Placement of Shares 22

Northwest Biotherapeutics Completes Private Placement Of Shares For US$15 Million 23

Northwest Biotherapeutics Completes Public Offering Of Units For US$27 Million 24

Northwest Biotherapeutics Completes Private Placement Of Units For US$15 Million 25

Northwest Biotherapeutics Completes Private Placement Of Shares For US$10 Million 27

Northwest Biotherapeutics Completes Public Offering Of Shares For US$14 Million 27

Northwest Biotherapeutics Completes Private Placement Of Shares For US$5 Million 29

Northwest Biotherapeutics Announces Private Placement Of Shares For US$3 Million 30

Northwest Biotherapeutics Raises USD17.5 Million in Private Placement of 5% Notes Due 2017 31

Northwest Biotherapeutics Completes Private Placement Of Convertible Notes For US$3 Million 32

Northwest Biotherapeutics Inc, Key Competitors 34

Northwest Biotherapeutics Inc, Key Employees 35

Northwest Biotherapeutics Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Northwest Biotherapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com